|
|
Volumn 26, Issue 18, 2008, Pages 3100-
|
|
Nonmetastatic pancreatic cancer: Many trials, little progress
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
GEMCITABINE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
ADJUVANT CHEMOTHERAPY;
CANCER CONTROL;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
HEALTH CARE COST;
HUMAN;
INOPERABLE CANCER;
LETTER;
MEDICAL ETHICS;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
PANCREAS CANCER;
PATIENT CARE;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
ADJUVANT THERAPY;
NOTE;
PANCREAS TUMOR;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
CLINICAL TRIALS, PHASE I AS TOPIC;
CLINICAL TRIALS, PHASE II AS TOPIC;
DEOXYCYTIDINE;
HUMANS;
NEOADJUVANT THERAPY;
PANCREATIC NEOPLASMS;
|
|
EID: 46449124841
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.16.9326 Document Type: Letter |
|
Times cited : (6)
|
|
References (5)
|
